Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital

Sapporo, Hokkaido 060-0033

0 studies enrolling now · 9 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission — Stopped early
• A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease — Completed
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis — Completed
• A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease — Completed
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis — Completed
• A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease — Completed
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis — Completed